» Articles » PMID: 26895791

Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development

Overview
Journal Diabetes
Specialty Endocrinology
Date 2016 Feb 21
PMID 26895791
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Increased coexistence of Alzheimer disease (AD) and type 2 diabetes mellitus (T2DM) suggests that insulin resistance abets neurodegenerative processes, but linkage mechanisms are obscure. Here, we examined insulin signaling factors in brains of insulin-resistant high-fat-fed mice, ob/ob mice, mice with genetically impaired muscle glucose transport, and monkeys with diet-dependent long-standing obesity/T2DM. In each model, the resting/basal activities of insulin-regulated brain protein kinases, Akt and atypical protein kinase C (aPKC), were maximally increased. Moreover, Akt hyperactivation was accompanied by hyperphosphorylation of substrates glycogen synthase kinase-3β and mammalian target of rapamycin and FOXO proteins FOXO1, FOXO3A, and FOXO4 and decreased peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) expression. Akt hyperactivation was confirmed in individual neurons of anterocortical and hippocampal regions that house cognition/memory centers. Remarkably, β-amyloid (Aβ1-40/42) peptide levels were as follows: increased in the short term by insulin in normal mice, increased basally in insulin-resistant mice and monkeys, and accompanied by diminished amyloid precursor protein in monkeys. Phosphorylated tau levels were increased in ob/ob mice and T2DM monkeys. Importantly, with correction of hyperinsulinemia by inhibition of hepatic aPKC and improvement in systemic insulin resistance, brain insulin signaling normalized. As FOXOs and PGC-1α are essential for memory and long-term neuronal function and regeneration and as Aβ1-40/42 and phospho-tau may increase interneuronal plaques and intraneuronal tangles, presently observed aberrations in hyperinsulinemic states may participate in linking insulin resistance to AD.

Citing Articles

Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition.

Yoo J, Lee J, Ahn B, Han J, Lim M Chem Sci. 2025; 16(5):2105-2135.

PMID: 39810997 PMC: 11726323. DOI: 10.1039/d4sc06762b.


Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors.

Liu S, Liu T, Li J, Hong J, Moosavi-Movahedi A, Wei J Neurosci Bull. 2025; .

PMID: 39754628 DOI: 10.1007/s12264-024-01342-8.


Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities.

Ma M, Jing G, Tian Y, Yin R, Zhang M Mol Neurobiol. 2024; 62(2):2435-2449.

PMID: 39112768 PMC: 11772472. DOI: 10.1007/s12035-024-04417-9.


FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.

Teaney N, Cyr N Front Endocrinol (Lausanne). 2023; 14:1286838.

PMID: 37941908 PMC: 10629996. DOI: 10.3389/fendo.2023.1286838.


Insulin and aging - a disappointing relationship.

Kolb H, Kempf K, Martin S Front Endocrinol (Lausanne). 2023; 14:1261298.

PMID: 37854186 PMC: 10579801. DOI: 10.3389/fendo.2023.1261298.


References
1.
MacPherson R, Baumeister P, Peppler W, Wright D, Little J . Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice. J Appl Physiol (1985). 2015; 119(10):1097-104. PMC: 4816412. DOI: 10.1152/japplphysiol.00299.2015. View

2.
Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L . Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging. 2013; 34(6):1581-8. PMC: 3632303. DOI: 10.1016/j.neurobiolaging.2012.12.005. View

3.
Qin W, Haroutunian V, Katsel P, Cardozo C, Ho L, Buxbaum J . PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol. 2009; 66(3):352-61. PMC: 3052997. DOI: 10.1001/archneurol.2008.588. View

4.
Nuzzo D, Picone P, Baldassano S, Caruana L, Messina E, Marino Gammazza A . Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease. Curr Alzheimer Res. 2015; 12(8):723-35. DOI: 10.2174/1567205012666150710115506. View

5.
Hansen B . Investigation and treatment of type 2 diabetes in nonhuman primates. Methods Mol Biol. 2012; 933:177-85. DOI: 10.1007/978-1-62703-068-7_11. View